CRISPR Therapeutics AG
SWB:1CG
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
CRISPR Therapeutics AG
SWB:1CG
|
CH |
|
M
|
MorphoSys AG
SWB:MOR
|
DE |
|
I
|
Implenia AG
XBER:I8T
|
CH |
|
M
|
MorphoSys AG
XHAM:MOR
|
DE |
|
J
|
Jabil Inc
SWB:JBL
|
US |
|
R
|
Roularta Media Group NV
LSE:0HC8
|
BE |
|
Cosmo Energy Holdings Co Ltd
TSE:5021
|
JP |
|
N4 Pharma PLC
F:0GO
|
UK |
|
L
|
LHN Ltd
HKEX:1730
|
SG |
|
A
|
Aegean Airlines SA
LSE:0OHY
|
GR |
|
E
|
Elvalhalcor Hellenic Copper and Aluminium Industry SA
F:HC6A
|
GR |
|
J
|
JBT Marel Corp
DUS:JBT
|
US |
|
A
|
AirAsia X Bhd
KLSE:AAX
|
MY |
|
Weave Communications Inc
NYSE:WEAV
|
US |
|
Peugeot Invest SA
PAR:PEUG
|
FR |
|
P
|
Piedmont Lithium Inc
F:6S3
|
US |
|
T
|
Ternium SA
F:T5Z
|
LU |
|
A
|
AGS Transact Technologies Ltd
BSE:543451
|
IN |
|
Meiji Holdings Co Ltd
F:3M00
|
JP |
|
H
|
Heineken Holding NV
DUS:4H5
|
NL |
|
Publicis Groupe SA
PAR:PUB
|
FR |
|
A
|
Argo Blockchain PLC
NASDAQ:ARBK
|
UK |
|
R
|
Reckitt Benckiser Group PLC
SWB:3RB
|
UK |
|
F
|
First Mining Gold Corp
OTC:FFMGF
|
CA |
Wall St Price Targets
1CG Price Targets Summary
CRISPR Therapeutics AG
According to Wall Street analysts, the average 1-year price target for
1CG is 71.935 EUR with a low forecast of 29.269 EUR and a high forecast of 268.324 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 1CG's stock price target?
Price Target
71.935
EUR
According to Wall Street analysts, the average 1-year price target for
1CG is 71.935 EUR with a low forecast of 29.269 EUR and a high forecast of 268.324 EUR.
What is the Revenue forecast for CRISPR Therapeutics AG?
Projected CAGR
119%
Over the last 10 years, the compound annual growth rate for Revenue has been 33%. The projected CAGR for the next 8 years is 119%.